Related Experiment Videos
CDKN2A (p16INK4A) somatic and germline mutations
1Department of Genetics, Norwegian Radium Hospital, Oslo Norway.
Abstract:
The cell cycle is composed of a series of steps that can be negatively or positively regulated by various factors. A group of low-molecular-weight proteins have recently been identified that specifically inhibit the function of cyclin-dependent kinases in mammalian cells. Inactivation of the CDKN2A gene (also known as p16INK4A and MTS1) attracted considerable interest after it was mapped to 9p21, a locus for familial melanoma. In an effort to standardize the information regarding human CDKN2A mutations detected in cancers, a database with information of 146 point mutations has been created. Cancer type, origin of cells, specific mutation, amino acid change, literature citation, and other data are provided for each mutation entry. Studies of biochemical and biological functions of both wild-type and mutant proteins are central to our understanding of the role of p16INK4a mutations in tumorigenesis, a summary of these studies is also included in the present update.
Insights
A database of 146 human CDKN2A gene mutations in cancer was created to standardize information. This resource aids understanding of p16INK4a's role in tumorigenesis.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- The cell cycle is regulated by various factors, including proteins that inhibit cyclin-dependent kinases.
- The CDKN2A gene (p16INK4A/MTS1) is crucial in cell cycle regulation and is frequently altered in cancers.
- Inactivation of CDKN2A at the 9p21 locus is linked to familial melanoma, highlighting its significance in cancer development.
Purpose of the Study:
- To create a standardized database of human CDKN2A gene mutations found in various cancers.
- To compile comprehensive information on 146 point mutations, including cancer type, cell origin, mutation details, and amino acid changes.
- To summarize current research on the biochemical and biological functions of p16INK4a, aiding the understanding of its role in tumorigenesis.
Main Methods:
- Database creation and curation.
- Systematic collection of data on CDKN2A point mutations from scientific literature.
- Literature review and summarization of studies on p16INK4a protein function.
Main Results:
- A database containing 146 human CDKN2A point mutations has been established.
- Each entry includes detailed information such as cancer type, cell origin, specific mutation, and amino acid alterations.
- The database serves as a centralized resource for researchers studying CDKN2A in cancer.
Conclusions:
- Standardized information on CDKN2A mutations is essential for cancer research.
- The compiled database facilitates a deeper understanding of p16INK4a's function and its implications in tumorigenesis.
- Further studies on p16INK4a mutations will advance our knowledge of cancer development and potential therapeutic strategies.